How is the Bluejay Diagnostics Inc today?

The Bluejay Diagnostics Inc today is trading in the green, up by 1.63% at 1.87.

How has Bluejay Diagnostics Inc performed historically?

The Bluejay Diagnostics Inc is currently trading up 1.63% on an intraday basis in the past week the index rose 9.36%. The index has been down -45.80% in the past quarter and fell -54.17% in the past year. You can view this in the overview section.

What is Bluejay Diagnostics Inc Annual Net Profit?

Bluejay Diagnostics Inc Annual Net Profit rose 22.46% in the last year to $7.72 M. Its sector's average net profit growth for the last fiscal year was 6.29%.

What is Bluejay Diagnostics Inc Price to Earning Ratio?

Bluejay Diagnostics Inc Price to Earning Ratio is -0.39, which is negative.

What is Bluejay Diagnostics Inc Stock Price?

Bluejay Diagnostics Inc Stock Price fell 54.17% and underperformed its sector by 61.53% in the past year.

What is Bluejay Diagnostics Inc Quarterly Net profit?

Bluejay Diagnostics Inc Quarterly Net profit rose 19.93% YoY to $1.86 M. Its sector's average net profit growth YoY for the quarter was 43.33%.

What is Bluejay Diagnostics Inc Debt to Equity Ratio?

Bluejay Diagnostics Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Bluejay Diagnostics Inc Return on Equity(ROE)?

Bluejay Diagnostics Inc Return on Equity(ROE) for the last financial year was -485.62%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Bluejay Diagnostics Inc Mutual Fund Holding?

Bluejay Diagnostics Inc Mutual Fund Holding increased by 0.21% in the last quarter to 0.34.

What is Bluejay Diagnostics Inc Interest Coverage Ratio?

Bluejay Diagnostics Inc Interest Coverage Ratio is -8.38, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Bluejay Diagnostics Inc XNAS: BJDX

Bluejay Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Name: Bluejay Diagnostics Inc: Is Infosys Ltd. worth buying?
Item: Bluejay Diagnostics Inc
Rating: 1.27750
Author: Trendlyne DVM scores

about

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test...

1.87 0.03 (1.63%)

81.67% Fall from 52W High

4,846 XNAS Volume

XNAS 22 May, 2025 9:47 AM (EDT)

Board Meeting

The latest board meeting for Bluejay Diagnostics Inc took place on 21 May 2025, for the purpose of Bluejay Diagnostics Inc Annual General Meeting for 2024 See details

Not Eligible

Expensive Valuation

15.5 / 100

Technically Neutral

35.6 / 100

No estimates available

Bluejay Diagnostics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bluejay Diagnostics Inc Live Share Price Today, Share Analysis and Chart

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test...

81.67% Fall from 52W High

SWOT Analysis

Bluejay Diagnostics Inc Live Price Chart

Bluejay Diagnostics Inc FAQ

How is Bluejay Diagnostics Inc today?

Bluejay Diagnostics Inc today is trading in the green, and is up by 1.63% at 1.87.

How has Bluejay Diagnostics Inc performed historically?

Bluejay Diagnostics Inc is currently trading up 1.63% on an intraday basis. In the past week the stock rose 9.36%. stock has been down -45.80% in the past quarter and fell -54.17% in the past year. You can view this in the overview section.